Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. Breastfeeding

Do you know that important immune protective proteins are present in breast milk? Breast milk also contains required vitamins, minerals, saturated and un saturated fats. These things are extremely important for development of healthy brain. If you are taking any medicine for short term or for the chronic reason then that passes in breast milk as well, that is why you should always check the drug with your health care provider. Here at DrLact we try to analyze drugs based on available researches and in this sheet we will present our analysis for Clopidogrel Bisulfate | Blenheim Pharmacal, Inc..

What is Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. used for?


Clopidogrel bisulfate is a P2Y12 platelet inhibitor indicated for: •Acute coronary syndrome 1.For patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)] including patients who are to be managed medically and those who are to be managed with coronary revascularization, clopidogrel has been shown to decrease the rate of a combined endpoint of cardiovascular death, myocardial infarction (MI), or stroke as well as the rate of a combined endpoint of cardiovascular death, MI, stroke, or refractory ischemia. (1.1) 2.For patients with ST-elevation myocardial infarction (STEMI), clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction, or stroke. The benefit for patients who undergo primary PCI is unknown. (1.1) •Recent myocardial infarction (MI), recent stroke, or established peripheral arterial disease. clopidogrel has been shown to reduce the combined endpoint of new ischemic stroke (fatal or not), new MI (fatal or not), and other vascular death. (1.2) 1.1 Acute Coronary Syndrome (ACS) •For patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)], including patients who are to be managed medically and those who are to be managed with coronary revascularization, clopidogrel bisulate has been shown to decrease the rate of a combined endpoint of cardiovascular death, myocardial infarction (MI), or stroke as well as the rate of a combined endpoint of cardiovascular death, MI, stroke, or refractory ischemia. •For patients with ST-elevation myocardial infarction (STEMI), clopidogdrel bisulfate has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction, or stroke. The benefit for patients who undergo primary percutaneous coronary intervention is unknown. The optimal duration of clopidogrel bisulfate therapy in ACS is unknown. 1.2 Recent MI, Recent Stroke, or Established Peripheral Arterial Disease For patients with a history of recent myocardial infarction (MI), recent stroke, or established peripheral arterial disease, clopidogrel bisulfate has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new MI (fatal or not), and other vascular death.

Is using Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. high risk while breastfeeding
As Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. is made of only Clopidogrel, and Clopidogrel is unsafe to use in breastfeeding we can safely reach on conclusion that Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. is also unsafe to use while breastfeeding. Below is detailed analysis of Clopidogrel and Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Studies in rats have shown that clopidogrel and/or its metabolites are excreted in the milk. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from clopidogrel, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. Breastfeeding Analsys


Clopidogrel while Breastfeeding

Unsafe

CAS Number: 90055-48-4

Though no adverse effects have been described yet, it should be given cautiously since a potent inhibitory effect on platelet aggregation is likely.


Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. Breastfeeding Analsys - 2


Clopidogrel while Breastfeeding

CAS Number: 120202-66-6

No published information is available on the use of clopidogrel during breastfeeding. The manufacturer reports that no adverse effects have been observed in breastfed infants with maternal clopidogrel use during lactation in a small number of postmarketing cases. If clopidogrel is required by the mother, it is not a reason to discontinue breastfeeding. However, since no published information is available on the use of clopidogrel during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.


Is Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. safe while breastfeeding

I already used Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. and meanwhile I breastfed my baby should I be concerned?

We have already established that Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. is unsafe in breastfeeding and breastfeeding while using Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


My health care provider has asked me to use Clopidogrel Bisulfate | Blenheim Pharmacal, Inc., what to do?

If your doctor knows that you are breastfeeding mother and still prescribes Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. then there must be good reason for that as Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Clopidogrel Bisulfate | Blenheim Pharmacal, Inc., will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Clopidogrel Bisulfate | Blenheim Pharmacal, Inc. in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week